A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer

British Journal of Cancer

Volumn 78, Issue 1, 1998, Pages 6-13

  Gulliford, T ^a   English, J ^a   Colston, K W ^b   Menday, P ^c   Moller, S ^d   Coombes, R C ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c Leo Pharmaceuticals   (United Kingdom)

^d LEO PHARMA A S   (Denmark)

Author keywords

Calcitriol; Cancer therapy; Differentiation agents

Indexed keywords

CALCIUM; CREATININE; PARATHYROID HORMONE; SEOCALCITOL; VITAMIN D DERIVATIVE;

ADULT; ADVANCED CANCER; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; CALCIUM METABOLISM; CALCIUM URINE LEVEL; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CREATININE URINE LEVEL; DOSE RESPONSE; DRUG TOLERABILITY; FATIGUE; FEMALE; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; MALE; MAXIMUM PERMISSIBLE DOSE; NAUSEA; ORAL DRUG ADMINISTRATION; PAIN; PARATHYROID HORMONE BLOOD LEVEL; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; VERTIGO; VOMITING;

EID: 0031806849     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.434     Document Type: Article

References (40)

1. Abe E, Miyaura C, Sakagami H, Takeda M, Konno K, Yamazaki T, Yoshiki S and Suda T (1981) Differentiation of mouse myeloid leukemia cells induced by 1 alpha, 25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 78: 4990-4994
2. Abe J, Morikawa M, Miyamoto K, Kaiho S, Fukushima M, Miyaura C, Abe E, Suda T and Nishii Y (1987) Synthetic analogues of vitamin D3 with an oxygen atom in the side chain skeleton. A trial of the development of vitamin D compounds which exhibit potent differentiation-inducing activity without inducing hypercalcaemia. Febs Lett 226: 58-62
3. 3 analog, EB 1089, inhibits growth of subcutaneous xenografts of the human colon cancer cell line, LoVo, in a nude mouse model. Dis Colon Rectum 40: 317-321
4. Bagot M, Grossman R, Pamphile R, Binderup L, Charue D, Revuz J and Dubertret L (1994) Additive effects of calcipotriol and cyclosporine A: from in vitro experiments to in vivo applications in the treatment of severe psoriasis. CR Acad Sci Iii 317: 282-286
5. Bar SZ, Teitelbaum SL, Reitsma P, Hall A, Pegg LE, Trial J and Kahn AJ (1983) Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 80: 5907-5911
6. Bell NH (1985) Vitamin D-endocrine system. J Clin Invest 76: 1-6
7. Berger U, Wilson P, McClelland RA, Colston K, Haussler MR, Pike JW and Coombes RC (1987) Immunocytochemical detection of 1,25-dihydroxyvitamin D3 receptor in breast cancer. Cancer Res 47: 6793-6795
8. Bertoli M, Luisetto G, Ruffatti A, Urso M and Romagnoli G (1990) Renal function during calcitriol therapy in chronic renal failure. Clin Nephrol 33: 98-102
9. Binderup L and Bramm E (1988) Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem Pharmacol 37: 889-895
10. Bower M, Colston KW, Stein RC, Hedley A, Gazet JC, Ford HT and Coombes RC (1991) Topical calcipotriol treatment in advanced breast cancer. Lancet 337: 701-702
11. Brehier A and Thomasset M (1988) Human colon cell line HT-29: characterisation of 1,25-dihydroxyvitamin D3 receptor and induction of differentiation by the hormone. J Steroid Biochem 29: 265-270
12. 3. Interplay with retinoid and thyroid hormone signalling. Eur J Biochem 231: 517-527
13. Colston K. Colston MJ and Feldman D (1981) 1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology 108: 1083-1086
14. Colston KW, Mackay AG, James SY, Binderup L, Chander S and Coombes RC (1992) EB1089: a new vitamin D analogue that inhibits the growth of breast cancer in vivo and in vitro. Biochem Pharmacol 44: 2273-2280
15. Eisman JA, Barkla DH and Tutton PJ (1987) Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3. Cancer Res 47: 21-25
16. Elstner E, Lee YY, Hashiya M, Pakkala S, Binderup L, Norman AW, Okamura WH and Koeffler HP (1994) 1 alpha,25-dihydroxy-20-epi-vitamin D3: an extraordinarily potent inhibitor of leukemic cell growth in vitro. Blood 84: 1960-1967
17. Elstner E, Linker-Israeli M, Umiel T, Le J, Grillier I, Said J, Shintaku IP, Krajewski S, Reed JC, Binderup L and Koeffler HP (1996) Combination of a potent 20-epi-vitamin D3 analogue (KH10060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells. Cancer Res 56: 3570-3576
18. Frampton RJ, Omond SA and Eisman JA (1983) Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites. Cancer Res 43: 4443-4447
19. Gordeladze JO, Halse J, Djooseland O and Haugen HNA (1978) Simple procedure for the determination of hydroxyproline in urine and bone. Biochem Med 20: 23-30
20. Gram J, Junker P, Nielsen HK and Bollerslev J (1996) Dose response effect of short-term calcitriol treatment on bone and mineral metabolism in normal males. Bone 18: 539-544
21. 3-regulated expression of the eukaryotic genome. Nutr Rev 52: 376-382
22. Hansen CM, Frandsen TL, Brunner N and Binderup L (1994) 1 alpha,25-dihydroxyvitamin D3 inhibits the invasive potential of human breast cancer cells in vitro. Clin Exp Metastasis 12: 195-202
23. Hayward JL and Rubens RD (1987) UICC Multidisciplinary Project on breast cancer. Management of early and advanced breast cancer. Int J Cancer 39: 1-5
24. Haq M, Kremer R, Goltzman D and Rabbani SA (1993) A vitamin D analogue (EB 1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcaemia in vivo. J Clin Invest 91: 2416-2422
25. Hosomi J, Hosoi J, Abe E, Suda T and Kuroki T (1983) Regulation of terminal differentiation of cultured mouse epidermal cells by 1 alpha,25-dihyroxyvitamin D3. Endocrinology 113: 1950-1957
26. James SY, Mackay AG, Binderup L and Colston KW (1994) Effects of a new synthetic vitamin D analogue. EB 1089, on the oestrogen-responsive growth of human breast cancer cells. J Endocrinol 141: 555-563
27. James SY, Mackay AG and Colston KW (1995) Vitamin D derivatives in combination with 9-cis-retinoic acid promote active cell death in breast cancer cells. J Mol Endocrinol 14: 391-394
28. Kragballe K (1992) Vitamin D analogues in the treatment of psoriasis. J Cell Biochem 49: 46-52
29. Kragballe K, Gjertsen BT, De Hoop D, Karlsmark T, van de Kerkhof PC, Larko O, Nieboer C, Roed Petersen J, Strand A and Tikjob G (1991) Double-blind. right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 337: 193-196
30. Majewski S, Szmurlo A, Marczak M, Jablonska S and Bollag W (1993) Inhibition of tumor cell-induced angiogenesis by retinoids, 1,25-dihydroxyvitamin D3 and their combination. Cancer Lett 75: 35-39
31. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P and Evans RM (1995) The nuclear receptor superfamily: the second decade. Cell 83: 835-839
32. Moller S (1995) An extension of the continual reassessment methods using a preliminary up-and-down design in dose finding study in cancer patients, in order to investigate a greater range of doses. Stat Med 14: 911-922
33. Norman AW, Zhou JY, Henry HL, Uskokovic MR and Koeffler HP (1990) Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption. Cancer Res 50: 6857-6864
34. O'Quigley J, Pepe M and Fisher L (1990) Continual reassessment method: a practical design for phase 1 clinical trials in cancer. Biometrics 46: 33-48
35. Ostrem VK, Lau WF, Lee SH, Perlman K, Prahl J, Schnoes HK and DeLuca HF (1987) Induction of monocytic differentiation of HL-60 cells by 1,25-dihydroxyvitamin D analogs. J Biol Chem 262: 1464-1471
36. Skowronski RJ, Peehl DM and Feldman D (1993) Vitamin D and prostate cancer: 1,25-dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines. Endocrinology 132: 1952-1960
37. Thomas MG, Tebbutt S and Williamson RC (1992) Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line. Gut 33: 1660-1663
38. Tvedegaard E and Madsen S (1988) Alphacalcidol and renal function in normal subjects. Min Electrolyte Metab 14: 158-162
39. Vieth R (1990) The mechanisms of vitamin D toxicity. Bone Min 11: 267-272
40. Zhou JY, Norman AW, Chen DL, Sun GW, Uskokovic M and Koeffler HP (1990) 1,25-dihydroxy-16-ene-23-yne-vitamin D-3 prolongs survival time of leukemic mice. Proc Natl Acad Sci USA 87: 3929-3932